ETPharma.com brings latest boehringer ingelheim news, views and updates from all top sources for the Indian Pharma industry.
Lupin Limited's commercial partner Sandoz has launched the ranibizumab biosimilar Ranluspec in Europe, targeting various ocular disorders. The move strengthens Lupin's position in the biosimilars ...
Amgen's late-stage trial results reveal that its experimental drug, dazodalibep, significantly reduces disease activity in ...
Pfizer has entered a strategic co-funding partnership with Blackstone, raising $1.5 billion to further develop its monthly ...
Aspen Pharmacare gains regulatory approval to market its generic injectable semaglutide in Brazil and South Africa, targeting growth in diabetes and obesity treatments following the expiration of ...
Novo Nordisk has announced a $200 million commitment to the World Diabetes Foundation to enhance diabetes prevention and care ...
Lupus patients are showing an increasing willingness to pursue experimental CAR-T therapies, even after recent fatalities in ...
Discover how drugmakers in China are leveraging AI applications to enhance doctor engagement in a post-corruption crackdown ...
India plans to overhaul its pharmaceutical regulatory framework to attract global drug companies for first-in-human clinical ...
Mania: J&J gained access to Caplyta through its $14.6 billion acquisition of Intra-Cellular Therapies last year to bolster ...
The National Pharmaceutical Pricing Authority has revised the retail price of Oxaliplatin, an essential chemotherapy drug, ...
The CDSCO has directed state drug regulators to fast-track their onboarding process for SUGAM, highlighting slow progress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results